Feinstein Institute for Medical Research

Northwell Launches Lung Transplant Program

Retrieved on: 
Monday, January 31, 2022

Northwell Health today announced that it has begun listing patients who need a lung transplant through the United Network for Organ Sharing (UNOS), the final steps toward opening the first lung transplant program serving Long Island and Queens residents.

Key Points: 
  • Northwell Health today announced that it has begun listing patients who need a lung transplant through the United Network for Organ Sharing (UNOS), the final steps toward opening the first lung transplant program serving Long Island and Queens residents.
  • View the full release here: https://www.businesswire.com/news/home/20220131005659/en/
    As the number of New Yorkers requiring a lung transplant have tripled over the last decade, the Northwell Health Transplant Center at North Shore University Hospital (NSUH) launched its program to fill an urgent need.
  • With the addition of lung, NSUH now offers world-class solid organ transplantation services for adult heart, kidney liver and lung.
  • Half of all lung transplant recipients at New York City hospitals traveled from Long Island, Queens, Brooklyn or Staten Island, said Zachary Kon, MD , surgical director of advanced lung failure and lung transplantation services at Northwell.

Feinstein Institutes Awarded $2.7M From NIH to Research Shock, Sepsis Therapeutic Targets

Retrieved on: 
Thursday, January 27, 2022

Researchers at The Feinstein Institutes for Medical Research have been awarded a five-year, $2.7 million grant from the National Institutes of Health (NIH) to better understand HS and how it can lead to increased infection and sepsis.

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research have been awarded a five-year, $2.7 million grant from the National Institutes of Health (NIH) to better understand HS and how it can lead to increased infection and sepsis.
  • Led by Ping Wang, MD, professor & chief scientific officer at the Feinstein Institutes, new studies will explore the molecular mechanisms and potential therapeutic drug targets for those experiencing HS and its related complications.
  • View the full release here: https://www.businesswire.com/news/home/20220127005109/en/
    Photo Caption: Ping Wang, MD, professor & chief scientific officer at the Feinstein Institutes.
  • The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State.

Northwell Cardiothoracic Programs Recognized for Top Performance by Society of Thoracic Surgeons

Retrieved on: 
Friday, January 21, 2022

The latest report included data from 906 cardiothoracic surgical programs across the United States and Canada.

Key Points: 
  • The latest report included data from 906 cardiothoracic surgical programs across the United States and Canada.
  • View the full release here: https://www.businesswire.com/news/home/20220121005482/en/
    Cardiothoracic surgical team at Sandra Atlas Bass Heart Hospital performs open-heart surgery.
  • Photo credit: Northwell Health
    The Sandra Atlas Bass Heart Hospital (SABHH) at NSUH has achieved three-star overall quality ratings the highest possible performance rating in all five cardiac surgical categories analyzed by the STS.
  • Achieving top performance in every cardiac surgery category, which the Sandra Atlas Bass Heart Hospital did, is truly a significant accomplishment.

The Alliance for Advancing Bioelectronic Medicine Launches the First Bioelectronic Medicine Day

Retrieved on: 
Tuesday, January 18, 2022

Geneva, Switzerland, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Alliance for Advancing Bioelectronic Medicine (AABM) today announced the official launch of the first Bioelectronic Medicine Day, a global health awareness campaign that will recognize October 8, 2022, as a day to support the efforts and advancements within the field of bioelectronic medicine.

Key Points: 
  • Geneva, Switzerland, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Alliance for Advancing Bioelectronic Medicine (AABM) today announced the official launch of the first Bioelectronic Medicine Day, a global health awareness campaign that will recognize October 8, 2022, as a day to support the efforts and advancements within the field of bioelectronic medicine.
  • We want this to be the day that the entire bioelectronic medicine community joins together to speak with one voice to raise the profile of this community, said Mario Ottiglio, Co-Founder of the Alliance for Advancing Bioelectronic Medicine, during a recent AABM webinar .
  • Bioelectronic Medicine Day aims to increase stakeholder engagement and collaboration, and continue to grow public awareness about bioelectronic medicine and its long-term potential.
  • The Alliance for Advancing Bioelectronic Medicine (AABM) encourages parties inside and outside the fieldto join and support the initiative that recognizes October 8th, 2022 the 64th anniversary of thefirst electronic implantable pacemaker as the official Bioelectronic Medicine Day.

Feinstein Institutes Bioelectronic Medicine Scientists Develop First-of-its-Kind Wireless Neuromodulation Device for Research

Retrieved on: 
Wednesday, January 19, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220119005185/en/
    Pictured is a second generation version of the wireless neuromodulation implantable mouse stimulator developed at the Feinstein Institutes.
  • (Credit: Feinstein Institutes)
    Bioelectronic medicine is a new approach to treating and diagnosing disease and injury that has emerged from the Feinstein Institutes labs.
  • The teams research builds off previous studies unveiled by the Feinstein Institutes the global scientific home of bioelectronic medicine.
  • Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine.

Inflammation Protein Contributes to Anemia of Chronic Disease by Preventing Red Blood Cell Formation

Retrieved on: 
Tuesday, January 18, 2022

(Credit: Feinstein Institutes)

Key Points: 
  • (Credit: Feinstein Institutes)
    For those with ACD, inflammation prevents the body from using stored iron to make enough healthy red blood cells, leading to anemia.
  • Common hormone therapy to promote blood cell formation erythropoietin (EPO) treatment has been shown ineffective for those with ACD.
  • You need red blood cells to carry oxygen throughout the body; the inability to do so is known as anemia.
  • Patients with chronic inflammation often develop anemia, but the molecular understanding remains unclear, said Dr. Blanc, corresponding author of the study.

Northwell Appoints Chief Quality Officer

Retrieved on: 
Monday, January 10, 2022

Northwell Health today announced the appointment of Peter Silver, MD, MBA , as senior vice president and chief quality officer.

Key Points: 
  • Northwell Health today announced the appointment of Peter Silver, MD, MBA , as senior vice president and chief quality officer.
  • Northwell will look to Dr. Silver to roll out strategies to improve quality and patient safety, ensuring that the health system continually raises the bar on safety standards and clinical processes while placing patient well-being first, said Jill Kalman, MD , senior vice president, chief medical officer and deputy physician-in-chief at Northwell.
  • In his new role, Dr. Silver will work closely with Karen Nelson, RN, senior vice president and deputy chief quality officer, Donna Armellino, RN, DNP, senior vice president of infection control, and Bruce Farber, MD , chief of infectious diseases.
  • Dr. Jarrett spent four decades serving the region, first at Staten Island University Hospital, and for the last decade, as Northwells chief quality officer.

Feinstein Institutes’ Christina Brennan Named to Association of Clinical Research Professionals Board

Retrieved on: 
Friday, January 7, 2022

Christina Brennan, MD, MBA, vice president of clinical research at Northwell Healths Feinstein Institutes for Medical Research , has been elected by members of the Association of Clinical Research Professionals (ACRP) to serve on its Board of Trustees for a second term.

Key Points: 
  • Christina Brennan, MD, MBA, vice president of clinical research at Northwell Healths Feinstein Institutes for Medical Research , has been elected by members of the Association of Clinical Research Professionals (ACRP) to serve on its Board of Trustees for a second term.
  • View the full release here: https://www.businesswire.com/news/home/20220107005283/en/
    Christina Brennan, MD, MBA is the vice president of clinical research at the Feinstein Institutes for Medical Research.
  • (Photo: Business Wire)
    Especially in these ever-changing times and focus on clinical research, it is an honor to be elected to the ACRPs Board of Trustees once again, said Dr. Brennan.
  • The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State.

Northwell CEO Michael Dowling Recognized as One of the “Most Influential People in Healthcare”

Retrieved on: 
Monday, December 20, 2021

Northwell Health President and CEO Michael J. Dowling , who leads the largest health care provider and private employer in New York State, has been named to Modern Healthcare magazines 100 Most Influential People in Healthcare, ranking third overall.

Key Points: 
  • Northwell Health President and CEO Michael J. Dowling , who leads the largest health care provider and private employer in New York State, has been named to Modern Healthcare magazines 100 Most Influential People in Healthcare, ranking third overall.
  • View the full release here: https://www.businesswire.com/news/home/20211220005538/en/
    Michael J. Dowling, President and CEO of Northwell Health (Photo: Business Wire)
    In Modern Healthcares 2021 list, Mr. Dowling ranked highest among 25 health care system or hospital CEOs nationwide.
  • This year, Albert Bourla, chairman & CEO of Pfizer Biopharmaceuticals, ranked first and Stephane Bancel, CEO of Moderna, ranked second.
  • Last year, Mr. Dowling ranked second on the health care magazines annual list only after frontline workers who were named first.

Feinstein Institutes Begins Pilot Trial to Reduce Cardiovascular Disease in the Black Community

Retrieved on: 
Thursday, December 16, 2021

The Feinstein Institutes for Medical Research , the science arm of Northwell Health , recently received a $150,000 grant from TD Bank, America's Most Convenient Bank, to launch a new research program and the first clinical trial to reduce cardiovascular disease (CVD) in the Black community and determine the best behavioral interventions to lower cardiovascular disease.

Key Points: 
  • The Feinstein Institutes for Medical Research , the science arm of Northwell Health , recently received a $150,000 grant from TD Bank, America's Most Convenient Bank, to launch a new research program and the first clinical trial to reduce cardiovascular disease (CVD) in the Black community and determine the best behavioral interventions to lower cardiovascular disease.
  • View the full release here: https://www.businesswire.com/news/home/20211216005126/en/
    Mark Butler, PhD, is the principal investigator on the new trial using smart prescription bottles.
  • CVD disproportionally affects the Black community, but this disparity could be addressed by increasing adherence to protocols for taking potentially life-saving medications.
  • Cardiovascular disease is a major driver of death, particularly among people in the Black community.